TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
This strategic expansion marks a significant step in the company's global growth strategy
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
The company expects meaningful revenue contribution from this long-term agreement
Investment demonstrates confidence in America’s commitment to science and innovation
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
